Cutler Group LP Siga Technologies Inc Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$5.0 - $6.31 $2,000 - $2,524	-400 Reduced 11.11%	3,200 $16,000
Q4 2022 Feb 07, 2023	SELL	$7.29 - $10.14 $51,394 - $71,487	-7,050 Reduced 66.2%	3,600 $26,000
Q3 2022 Oct 25, 2022	BUY	$10.02 - $26.15 $57,214 - $149,316	5,710 Added 115.59%	10,650 $109,000
Q2 2022 Aug 04, 2022	BUY	$6.5 - $13.68 $32,110 - $67,579	4,940 New	4,940 $57,000
Q1 2022 Apr 14, 2022	SELL	$5.96 - $7.61 $9,243 - $11,803	-1,551 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$6.96 - $9.26 $10,794 - $14,362	1,551 New	1,551 $11,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $432M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.